Down-regulating α-synuclein for treating synucleopathies-Reference-Cited by-同舟云学术

Down-regulating α-synuclein for treating synucleopathies

Published:2014-09-12 Issue:12 Volume:29 Page:1463-1465
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov Disord.

Author:

Bourdenx Mathieu¹,Dehay Benjamin¹,Bezard Erwan¹

Affiliation:

1. Institute of Neurodegenerative Diseases; University of Bordeaux, Centre National de la Recherche Scientifique Unité Mixte de Recherche; Bordeaux France

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Reference32 articles.

1. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease;Polymeropoulos;Science,1997

2. Alpha-synuclein in Lewy bodies;Spillantini;Nature,1997

3. Parkinson's disease and alpha synuclein: is Parkinson's disease a prion-like disorder?;Olanow;Mov Disord,2013

4. Slowing of neurodegeneration in Parkinson's disease and Huntington's disease: future therapeutic perspectives;Schapira;Lancet,2014

5. In vivo RNAi-mediated alpha-synuclein silencing induces nigrostriatal degeneration;Gorbatyuk;Mol Ther,2010

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systemic peptide mediated delivery of an siRNA targeting α-syn in the CNS ameliorates the neurodegenerative process in a transgenic model of Lewy body disease;Neurobiology of Disease;2019-07

2. The role of heparan sulfates in protein aggregation and their potential impact on neurodegeneration;FEBS Letters;2018-06-14

3. Protein aggregation and neurodegeneration in prototypical neurodegenerative diseases: Examples of amyloidopathies, tauopathies and synucleinopathies;Progress in Neurobiology;2017-08

4. Heparán sulfatos, amiloidosis y neurodegeneración;Revista de Neurología;2017

5. Melatonin Attenuates Methamphetamine-Induced Neurotoxicity;Current Pharmaceutical Design;2016-02-15